Author

M. Joy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:cell type annotation· 3 Organism:human· 3 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. V. LEE· 2 shared P. C. Lucas· 2 shared A. C. Soloff· 1 shared A. Hall· 1 shared A. Li· 1 shared B. Isett· 1 shared C. K. Anders· 1 shared C. Luedke· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

A. V. LEE

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

mDia2 is an important mediator of MRTF-A-dependent regulation of breast cancer cell migration

I. Eder, V. Yu, J. Antonello, F. Chen, D. Gau, P. Chawla, M. Joy, P. Lucas, D. Boone, A. V. LEE, P. Roy

This study identifies mDia2 as a mediator of MRTF-A-dependent breast cancer cell migration and links MRTF activity to malignancy, suggesting it as a therapeutic target.

bioRxiv · Dec 21, 2023Cell Biology

Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma

R. C. Augustin, S. Newman, A. Li, M. Joy, M. Lyons, M. Pham, P. C. Lucas, K. Smith, C. Sander, B. Isett, D. Davar, Y. G. Najjar, H. M. Zarour, J. M. Kirkwood, J. J. Luke, R. Bao

This study identifies 11 oncogenic pathways associated with immune exclusion and ICI resistance in acral melanoma, suggesting therapeutic targets for immunotherapy combinations.

bioRxiv · Aug 24, 2023Cell Biology

Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors

L. Zhu, J. L. Narloch, S. Onkar, M. Joy, C. Luedke, A. Hall, R. Kim, K. Pogue-Geile, S. Sammons, N. Nayyar, U. Chukwueke, P. K. Brastianos, C. K. Anders, A. C. Soloff, D. A. Vignali, , A. V. Lee

The paper compares immune cell infiltration in primary and metastatic breast tumors, finding reduced immune cell abundance but increased M2-like macrophages in metastases.

bioRxiv · Jan 20, 2019Immunology